Literature DB >> 28578518

Using Simulated Data to Assess Case-Crossover Designs for Studying Less Transient Effects of Drugs.

Malcolm Maclure1.   

Abstract

Mesh：

Year:  2017        PMID： 28578518     DOI： 10.1007/s40264-017-0549-7

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  9 in total

1.  Design and validation of a data simulation model for longitudinal healthcare data.

Authors:  Richard E Murray; Patrick B Ryan; Stephanie J Reisinger
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  When should case-only designs be used for safety monitoring of medical products?

Authors:  Malcolm Maclure; Bruce Fireman; Jennifer C Nelson; Wei Hua; Azadeh Shoaibi; Antonio Paredes; David Madigan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

3.  The case-crossover design: a method for studying transient effects on the risk of acute events.

Authors:  M Maclure
Journal:  Am J Epidemiol       Date:  1991-01-15       Impact factor: 4.897

4.  Persistent User Bias in Case-Crossover Studies in Pharmacoepidemiology.

Authors:  Jesper Hallas; Anton Pottegård; Shirley Wang; Sebastian Schneeweiss; Joshua J Gagne
Journal:  Am J Epidemiol       Date:  2016-11-15       Impact factor: 4.897

5.  Evaluation of the Case-Crossover (CCO) Study Design for Adverse Drug Event Detection.

Authors:  Zachary Burningham; Tao He; Chia-Chen Teng; Xi Zhou; Jonathan Nebeker; Brian C Sauer
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

6.  "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.

Authors:  Shirley V Wang; Sebastian Schneeweiss; Malcolm Maclure; Joshua J Gagne
Journal:  Am J Epidemiol       Date:  2014-08-01       Impact factor: 4.897

7.  Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.

Authors:  Martijn J Schuemie; Gianluca Trifirò; Preciosa M Coloma; Patrick B Ryan; David Madigan
Journal:  Stat Methods Med Res       Date:  2014-03-31       Impact factor: 3.021

8.  Triggering myocardial infarction by marijuana.

Authors:  M A Mittleman; R A Lewis; M Maclure; J B Sherwood; J E Muller
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

9.  Triggering of myocardial infarction by cocaine.

Authors:  M A Mittleman; D Mintzer; M Maclure; G H Tofler; J B Sherwood; J E Muller
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.